Baicalein (30 μM) pretreatment directly bound to the transcription factor FOXO3a, promoting its transcriptional activity and transactivation of catalase and FUNDC1 while increasing mitophagy expression, inhibiting the overproduction and accumulation of ROS, and attenuating ISO-induced cardiac hypertrophy. Here, FUNDC1 is linked to cardiac hypertrophy.